Comments Regarding FDA Diversity Action Plans to Improve Enrollment of Participants From Underrepresented Populations in Clinical Studies Share page: Docket Number: FDA–2021–D–0789 Download Document Issues: OTC Medicines Dietary Supplements Consumer Medical Devices Other Issues Research Related Posts Press Releases and Statements Rates for Teen Abuse of OTC Cough/Cold Medication Remains Low According to NIDA Survey Dec 18, 2024 Pediatric Cough/Cold Dosing Press Releases and Statements CHPA Joins U.S. Senators Grassley & Coons at Anti-Counterfeiting Event Dec 13, 2024